With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Expanding Innovative Pediatric Cancer Clinical Trial Access at Stanford||Stanford University / Maria-Grazia Roncarolo, M.D. & Sherri Spunt, M.D.||Phase I/II Infrastructure Grants||2015||California|
|Phase II Trial of Poly-ICLC in Pediatric Low Grade Gliomas||University of California, San Diego / Donald Durden, MD, PhD||Springboard Grants||2013||California|
|Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma||The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D.||Reach Grants||2014||California|
|Modeling Pediatric Leukemia in Zebra Fish to Enable Discovery of New Anti- Leukemic Compounds||University of California, San Diego / David Traver, MD||Innovation Grants||2010||California|
|Immunotherapeutic Targeting of Stem Cells in Pediatric Brain Tumors||Harbor - UCLA Medical Center / Joseph Lasky||Young Investigator Grants||2008||California|
|Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model||Stanford University / Michelle Monje, MD/PhD||Innovation Grants||2016||California|
|Developing and Distributing a Pediatric Spinal Cord High-grade Glioma Model||Stanford University / Michelle Monje, MD/PhD||Innovation Grants||2016||California|
|A Novel Target for Neuroblastoma Treatment||Beckman Research Institute of City of Hope / Linda Malkas, Ph.D.||Reach Grants||2014||California|
|Targeting inhibitory phosphatase signaling in high-risk childhood ALL||University of California San Francisco / Markus Muschen, MD, PhD||Innovation Grants||2011||California|
|Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG||Lucile Packard Children's Hospital at Stanford University School of Medicine / Yujie Tang, PhD||Young Investigator Grants||2014||California|